You'll be hearing about Project ImPACT
You'll be hearing about Project ImPACT...a two-year study to show how pharmacists can improve compliance in patients on cholesterol-lowering therapy.
It's being conducted by APhA and funded by Merck.
Pharmacists will use a nifty Cholestech machine. It determines cholesterol levels from a fingerstick blood sample...then calculates the patient's risk of developing coronary heart disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote